NCT00093171View on ClinicalTrials.gov

Study Evaluating rFIX; BeneFIX® in Hemophilia B

PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

Not specified

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Hemophilia B
Interventions
DRUG

rFIX

Trial Locations (7)

45404

Dayton

48201

Detroit

77030

Houston

80262

Aurora

90027

Los Angeles

08903

New Brunswick

27599-7016

Chapel Hill

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00093171 - Study Evaluating rFIX; BeneFIX® in Hemophilia B | Biotech Hunter | Biotech Hunter